Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
T Poynard, V Leroy, M Cohard, T Thevenot, P Mathurin, P Opolon, J P Zarski – 1 October 1996 – The aims of this study were to evaluate the benefits of higher doses or of longer duration in comparison with a standard interferon regimen (3 MU three times per week for 6 months) in chronic hepatitis C, and to assess the efficacy of interferon in acute hepatitis C. Meta‐analysis made use of the Peto et al. and the Der Simonian and Laird methods, with heterogeneity and sensitivity analyses.